New hope for Tough-to-Treat lymphoma: experimental drug DZD8586 under study
NCT ID NCT06539195
First seen Jan 07, 2026 · Last updated May 05, 2026 · Updated 19 times
Summary
This study tests an experimental drug called DZD8586 in 59 adults with diffuse large B-cell lymphoma that has returned or stopped responding to prior treatments. The goal is to see if the drug can shrink tumors and to understand its side effects and how the body processes it. Participants take the drug alone, without other cancer treatments, and are monitored closely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Clinical Research Center for Blood Diseases, Blood Disease Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin, Tianjin Municipality, 300020, China
-
Research Site
Hefei, Anhui, 230031, China
-
Research Site
Beijing, Beijing Municipality, 100083, China
-
Research Site
Guangzhou, Guangdong, 510060, China
-
Research Site
Nanning, Guangxi, 530016, China
-
Research Site
Zhengzhou, Henan, 450003, China
-
Research Site
Wuhan, Hubei, 430023, China
-
Research Site
Changsha, Hunan, 410031, China
-
Research Site
Jinan, Shandong, 250117, China
-
Research Site
Linyi, Shandong, 276002, China
-
Research Site
Xi’an, Shanxi, 710061, China
-
Research Site
Chengdu, Sichuan, 610041, China
-
Research Site
Tianjin, Tianjin Municipality, 300181, China
-
Research Site
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.